相关实验视频
Updated: Jun 9, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
997
托法西提尼布用于儿童发作的全身性红血性狼
Ling Hou1, Peng Zhou1, Chengguang Zhao1
1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Frontiers in immunology
|October 23, 2024
概括
托法西替尼可能对一些患有耐火性系统性红斑狼 (SLE) 的儿童有好处,可能减少他们对葡萄糖皮质激素的需求. 然而,并非所有患者都对这种Janus激酶 (JAK) 抑制剂治疗有反应.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 儿科 儿科 儿科
背景情况:
- 系统性红斑狼 (SLE) 是一种慢性自身免疫性疾病,在儿童中具有显著的发病率 (cSLE).
- 目前的SLE治疗有局限性,包括副作用和不完全的疾病控制.
- 托法西提尼布是一种简氏激酶 (JAK) 抑制剂,向JAK-STAT通路,并可能降低SLE的严重程度.
研究的目的:
- 评估托法西提尼布在患有耐火性cSLE的儿科患者中的疗效.
- 评估托法西提尼布在cSLE中降低葡萄糖皮质醇剂量的潜力.
主要方法:
- 对9名用托法西提尼布治疗的cSLE患者的回顾性检查.
- 分析患者病史,实验室结果和治疗方案.
- 在疾病发作,托法西提尼布开始和治疗后长达24个月时收集的数据.
主要成果:
- 在9名患有耐火性cSLE的女性患者中,有4名患者表现出症状缓解和降低了普得尼松剂量.
- 一些患者能够停止使用其他免疫抑制剂,如环素A和贝利马布.
- 五名患者从托法西提尼布治疗中没有明显的好处.
结论:
- 托法西替尼可能为一些患有耐火性cSLE的儿科患者提供临床益处.
- 它可以为一些cSLE患者减少葡萄糖皮质类药物治疗.
- 托法西提尼布在特定的cSLE病例中显示出作为辅助疗法的潜力.
更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)